Dishman Pharmaceuticals & Chemicals
BSE: 532526 | NSE: DISHMAN | ISIN: INE353G01020 | Pharmaceuticals
 |
Half Yearly Results of Dishman Pharmaceuticals & Chemicals |
------------------- in Rs. Cr. ------------------- |
| Sep '07 | Mar '08 | Sep '08 | Mar '09 | Sep '09 | ||||||
| ||||||||||
|
||||||||||
| 6 mths | 6 mths | 6 mths | 6 mths | 6 mths | ||||||
|
||||||||||
| Sales Turnover | 155.96 | 203.24 | 201.69 | 214.89 | 167.19 | |||||
| Other Income | 7.98 | -3.40 | -3.89 | 3.89 | -- | |||||
| Total Income | 163.94 | 199.84 | 197.80 | 218.78 | 167.19 | |||||
| Total Expenses | 119.06 | 148.07 | 125.71 | 153.53 | 108.03 | |||||
| Operating Profit | 36.90 | 55.17 | 75.98 | 61.36 | 59.16 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | -- | -1.82 | -6.82 | 6.41 | -0.48 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 44.88 | 51.77 | 72.09 | 65.25 | 59.16 | |||||
| Interest | 3.07 | 4.15 | 7.60 | 14.90 | 9.98 | |||||
| PBDT | 41.81 | 45.79 | 57.67 | 56.76 | 48.71 | |||||
| Depreciation | 8.31 | 8.50 | 9.38 | 10.41 | 10.35 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 33.50 | 37.29 | 48.29 | 46.35 | 38.36 | |||||
| Tax | 4.31 | 6.93 | 2.45 | 0.05 | 4.33 | |||||
| Net Profit | 29.19 | 30.36 | 45.84 | 46.30 | 34.03 | |||||
| Prior Year Income/Expenses | -0.01 | 0.01 | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share(Rs) | 3.77 | 3.81 | 5.68 | 5.74 | 4.22 | |||||
| Book Value(Rs) | -- | -- | -- | -- | -- | |||||
| Equity | 15.51 | 15.94 | 16.14 | 16.14 | 16.14 | |||||
| Reserves | -- | 445.51 | -- | -- | -- | |||||
| Face Value(Rs) | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Dishman Pharma connections | ||||||||||
| ||||||||||
